Charles Schwab Investment Management Inc Immunic, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 25,000 shares of IMUX stock, worth $19,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,000
-0.0%
Holding current value
$19,250
Previous $25,000
8.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
40.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$6.86 Million0.43% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$5.62 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.43 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$3.03 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$1.62 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $23.5M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...